CARVYKTI
For the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody
Related Articles
Their Physical Therapy Coverage Ran Out Before They Could Walk Again
Mari Villar was slammed by a car that jumped the curb, breaking her legs and collapsing a lung. Amy Paulo was in pain from a…
‘Not Accountable to Anyone’: As Insurers Issue Denials, Some Patients Run Out of Options
BRIDGEPORT, W.Va. — By the time Eric Tennant was diagnosed in 2023 with a rare cancer of the bile ducts, the disease had spread to…
Clinical Trial Identifies Potential Treatment for Asthma in Latino Children
Clinical trials can help researchers learn to better treat asthma – but they need diverse volunteers. Black and Latino children who have severe asthma, are prone to asthma attacks, and live in low-income urban neighborhoods are underrepresented in asthma treatment clinical trials, even though they are more likely than whites to face health inequities that …
The post Clinical Trial Identifies Potential Treatment for Asthma in Latino Children appeared first on Salud America.
ABECMA (idecabtagene vicleucel)
ABECMA is the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapies including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.
What Does Life Look Like with a Brain Tumor?
Of course, no one wants to hear they have cancer. But if you or someone in your familia has a brain tumor, it is natural to wonder what life will look like. This is what we call “quality of life” (QoL), or an individual’s sense of well-being and ability to enjoy and participate in life. …
The post What Does Life Look Like with a Brain Tumor? appeared first on Salud America.
